Vita-Xō™ exosomes are the essential communicators for human development as the building blocks for tissue growth, repair, and immune modulation. The physiological changes the mother/fetus experiences, tissue growth, and immune modulation originate with communication with the fetus via Vita-Xō™.
SKU: ZG-VITA-80180-A 1mL
Vita Xō™ – Flowable Amniotic Exosome Tissue – 1mL
• Cryopreserved • Membrane-bound vesicles released by cells into the amniotic fluid. • Facilitate cell to cell signaling and natural self-regeneration. • Harnessed from prescreened single birth donor amniotic fluid. • Stimulation of the body’s innate regenerative ability. • Medical literature has shown success in a wide array of pathologies. • Containing a cargo of intracellular messengers. + mRNA, miRNA, proteins, lipids, complex sugars.
Our proprietary methodology allows us to produce 1mL vials of Exosomes that are not expanded (thereby not exceeding the FDA’s definition of “beyond minimal manipulation”), exceed over 300 Billion EVs, and are less than 115nm in diameter.
Produced from amniotic fluid (cells), from pre-screened, C-Section, full-term donor mothers that are monitored through the entire birth process.
Vita-Xō exosomes are suspended in amniotic fluid which is the carrier.
Exosomes are small and can easily circulate through capillaries, whereas the cells in other cell-based therapies, such as MSCs, are too large. They cannot get beyond first pass capillary beds, such as the lungs.
AFMSC derived exosomes can avoid problems associated with the transfer of cells, which may already have damaged or mutated DNA  [due to aging cells.]
Vita-Xō exosomes, are minimally manipulated flowable tissue allograft, cryopreserved to protect the functionality of the peptides, growth factors, and intercellular messengers.
1.Detection technology: TRPS 2.Thaw frozen samples in 25ºC water bath, and place them on ice. 3.Samples were diluted with 1 × PBS and used directly for TRPS. 4.Instrument information: – Instrument model: qNano Gold – Software version for analysis: Izon Control Suite 3.3.2 – Instrument name: qNano nanoparticle analyzer
Vita-Xō Exosome Results
Three samples were characterized by qNano nanoparticle analyzer (qNano Gold). The test results are as follows:
1.The mean size and concentration of the RS-AS-1155 was 106 – (Std Dev=23.2) and 3.46E+9 particles/mL. 2.The mean size and concentration of the RS-AS-1156 was 110 – (Std Dev=7.9) and 4.42E+9 particles/mL. 3.The mean size and concentration of the RS-AS-1157 was 111 – (Std Dev=31.4) and 1.81E+9 particles/mL
In conclusion, the samples are in line with the exosome features.
*Equivalence Testing of Vita Xō™ was performed by a 3rd party testing facility, Creative Biolabs in NY.
Abstract Mammalian cells secrete two types of extracellular vesicles either constitutively or in a regulated manner: exosomes (50–100 nm in diameter) released from the intracellular compartment and ectosomes (also called [...]
Abstract Human amniotic fluid stem cells (hAFS) have shown a distinct secretory profile and significant regenerative potential in several preclinical models of disease. Nevertheless, little is known about the detailed [...]
Abstract Pheochromocytomas (PCCs) and paragangliomas (PGLs) are the most heritable endocrine tumors. Genetic testing for 12 driver susceptibility genes is recommended in all PCC and PGL cases. However, detection of [...]
Abstract Exosomes may constitute a more practical alternative to live cells in select stem cell-based therapies. We sought to compare exosomes from two mesenchymal stem cell (MSC) sources relevant to [...]
Abstract The application of stem cells as a therapy for degenerative disease holds great promise. Substantial evidence suggests that stem cell derived exosomes are a novel cell‑free therapy for the [...]
Abstract Studies completed to date provide persuasive evidence that placental cell-derived exosomes play a significant role in intercellular communication pathways that potentially contribute to placentation and development of materno-fetal vascular [...]